GB2082911B - Pharmaceutical compositions containing amino acids for promoting the healing of wounds - Google Patents

Pharmaceutical compositions containing amino acids for promoting the healing of wounds

Info

Publication number
GB2082911B
GB2082911B GB8126836A GB8126836A GB2082911B GB 2082911 B GB2082911 B GB 2082911B GB 8126836 A GB8126836 A GB 8126836A GB 8126836 A GB8126836 A GB 8126836A GB 2082911 B GB2082911 B GB 2082911B
Authority
GB
United Kingdom
Prior art keywords
wounds
healing
promoting
amino acids
pharmaceutical compositions
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
GB8126836A
Other languages
English (en)
Other versions
GB2082911A (en
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Ed Geistlich Soehne AG fuer Chemische Industrie
Original Assignee
Ed Geistlich Soehne AG fuer Chemische Industrie
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ed Geistlich Soehne AG fuer Chemische Industrie filed Critical Ed Geistlich Soehne AG fuer Chemische Industrie
Publication of GB2082911A publication Critical patent/GB2082911A/en
Application granted granted Critical
Publication of GB2082911B publication Critical patent/GB2082911B/en
Expired legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0014—Skin, i.e. galenical aspects of topical compositions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/32—Macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. carbomers, poly(meth)acrylates, or polyvinyl pyrrolidone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
    • A61K47/38—Cellulose; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L26/00—Chemical aspects of, or use of materials for, wound dressings or bandages in liquid, gel or powder form
    • A61L26/0061—Use of materials characterised by their function or physical properties
    • A61L26/0066—Medicaments; Biocides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L26/00—Chemical aspects of, or use of materials for, wound dressings or bandages in liquid, gel or powder form
    • A61L26/0061—Use of materials characterised by their function or physical properties
    • A61L26/008—Hydrogels or hydrocolloids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
    • A61L2300/20—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices containing or releasing organic materials
    • A61L2300/21—Acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
    • A61L2300/20—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices containing or releasing organic materials
    • A61L2300/21—Acids
    • A61L2300/214—Amino acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
    • A61L2300/40—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices characterised by a specific therapeutic activity or mode of action
    • A61L2300/45—Mixtures of two or more drugs, e.g. synergistic mixtures

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Inorganic Chemistry (AREA)
  • Materials Engineering (AREA)
  • Engineering & Computer Science (AREA)
  • Dispersion Chemistry (AREA)
  • Dermatology (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
GB8126836A 1980-09-04 1981-09-04 Pharmaceutical compositions containing amino acids for promoting the healing of wounds Expired GB2082911B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB8028554 1980-09-04

Publications (2)

Publication Number Publication Date
GB2082911A GB2082911A (en) 1982-03-17
GB2082911B true GB2082911B (en) 1984-04-18

Family

ID=10515840

Family Applications (1)

Application Number Title Priority Date Filing Date
GB8126836A Expired GB2082911B (en) 1980-09-04 1981-09-04 Pharmaceutical compositions containing amino acids for promoting the healing of wounds

Country Status (15)

Country Link
EP (1) EP0047647B1 (cg-RX-API-DMAC10.html)
JP (1) JPS5780316A (cg-RX-API-DMAC10.html)
AU (1) AU7486081A (cg-RX-API-DMAC10.html)
BE (1) BE890230A (cg-RX-API-DMAC10.html)
CA (1) CA1198679A (cg-RX-API-DMAC10.html)
CH (1) CH650148A5 (cg-RX-API-DMAC10.html)
DE (1) DE3173310D1 (cg-RX-API-DMAC10.html)
DK (1) DK390181A (cg-RX-API-DMAC10.html)
ES (1) ES8307491A1 (cg-RX-API-DMAC10.html)
FI (1) FI812708L (cg-RX-API-DMAC10.html)
FR (1) FR2489145A1 (cg-RX-API-DMAC10.html)
GB (1) GB2082911B (cg-RX-API-DMAC10.html)
IT (1) IT1209894B (cg-RX-API-DMAC10.html)
NZ (1) NZ198259A (cg-RX-API-DMAC10.html)
ZA (1) ZA816124B (cg-RX-API-DMAC10.html)

Families Citing this family (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0302536B1 (en) * 1982-04-22 1992-11-19 E.R. Squibb & Sons, Inc. Granules for use in treating wounds
EP0112852B1 (en) * 1982-06-24 1988-06-08 SMITH, Robert Alan Pharmaceutical gel composition
GR79380B (cg-RX-API-DMAC10.html) * 1982-09-28 1984-10-22 Johnson & Johnson Prod Inc
EP0137743A3 (en) * 1983-09-13 1986-10-01 Ed. Geistlich Söhne Ag Für Chemische Industrie Topically administrable pharmaceutical compositions
DD248961A1 (de) * 1984-05-22 1987-08-26 Akad Wissenschaften Ddr Verfahren zur herstellung wundheilungsfoerdernder praeparationen
NL8720257A (nl) * 1986-06-13 1988-05-02 Japan Immuno Res Lab Wondbehandelingspreparaat en kosmeticum.
EP0321709A3 (en) * 1987-12-23 1990-04-04 Francisco José Izundegui MacDonnell Fast healing and binding chemical compound or curative agent for healing wounded live animal and human soft tissues inflicted by cutting edges or separating forces
US4871718A (en) * 1987-12-29 1989-10-03 Raymond A. Roncari Composition of matter for increasing intracellular ATP levels and physical performance levels and for increasing the rate of wound repair
GB2276819B (en) * 1993-03-23 1996-12-11 Johnson & Johnson Medical Aqueous wound treatment composition comprising a polysaccharide and hexylene glycol
US5670169A (en) * 1993-12-20 1997-09-23 E.R. Squibb & Sons, Inc. Wound hydrating gel with novel preservative system and low cytotoxicity
GB2291348B (en) * 1994-07-18 1999-01-20 Johnson & Johnson Medical Sterile gel composition for wound treatment comprising alginate and polyhydric alcohol
AU3364297A (en) * 1997-04-02 1998-10-22 Tamaz Shalvovich Mchedlidze Ointments for treating suppurative lesions, burns and trophic ulcers at ll stages, preparation and applications of same
RU2165754C2 (ru) * 1997-04-02 2001-04-27 Мчедлидзе Тамаз Шалвович Мазь для лечения гнойновоспалительных заболеваний, ожогов, воспалительных заболеваний суставов, трофических язв и длительно незаживающих ран, способ ее приготовления и способ лечения
RU2138250C1 (ru) * 1997-06-23 1999-09-27 ОАО "Нижегородский химико-фармацевтический завод" Способ получения мази "диоксиколь"
RU2146923C1 (ru) * 1997-11-05 2000-03-27 Рязанский областной клинический кожно-венерологический диспансер Средство для лечения дерматозов
RU2146921C1 (ru) * 1997-11-05 2000-03-27 Рязанский областной клинический кожно-венерологический диспансер Мазевая композиция, стимулирующая регенерацию эпителия
RU2145497C1 (ru) * 1998-04-16 2000-02-20 Государственный научный центр лекарственных средств Средство для лечения гнойно-некротических процессов
RU2135180C1 (ru) * 1999-02-15 1999-08-27 Фармацевтическое научно-производственное предприятие "Ретиноиды" (акционерное общество закрытого типа) Мазь для заживления ран
EP1228771A4 (en) 1999-11-09 2003-01-29 Denki Kagaku Kogyo Kk USE OF SOLUBLE CELLULOSE DERIVATIVES MADE DIFFICULTLY SOLUBLE IN WATER AND METHOD OF PREPARING SUCH DERIVATIVES
WO2002094256A1 (en) * 2001-05-23 2002-11-28 Debatosh Datta Lysine and/or analogues and/or polymers thereof for promoting wound healing and angiogenesis
RU2349302C1 (ru) * 2007-09-21 2009-03-20 Виталий Георгиевич Пшеничников Фармацевтическая композиция для наружного применения "офломелид" при гнойно-воспалительных заболеваниях
US10413528B2 (en) * 2014-10-20 2019-09-17 John H. Plumb Methods to inhibit infection during wound healing with topical compositions including amino acids
WO2019035953A1 (en) * 2017-08-18 2019-02-21 Calwood Nutritionals, Llc COMPOSITIONS AND METHODS FOR INCREASING MUSCLE MASS AND MUSCLE STRENGTH, TREATING SKIN, REDUCING WEAR AND DEGRADING FROM AGING AND EXPOSURE AND ENHANCING RECOVERY OF A STRESS SUCH AS EXERCISE AND TRAUMA
RU2733714C2 (ru) * 2017-11-07 2020-10-06 Общество с ограниченной ответственностью "Трейдсервис" Стабильная комбинированная фармацевтическая композиция диоксидина и анестетиков

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3786076A (en) * 1966-10-13 1974-01-15 J Morelle Lipoaminoacids
FR2215212B1 (cg-RX-API-DMAC10.html) * 1973-01-18 1976-03-05 Seperic Ch
DE2438703C3 (de) * 1974-08-12 1980-02-21 Ernst Dr.Med. 4970 Bad Oeynhausen Lauven Verwendung einer Mischung bei der Rheumabehandlung

Also Published As

Publication number Publication date
BE890230A (fr) 1982-01-04
EP0047647A2 (en) 1982-03-17
DE3173310D1 (en) 1986-02-06
FI812708A7 (fi) 1982-03-05
DK390181A (da) 1982-03-05
ZA816124B (en) 1982-09-29
IT8149222A0 (it) 1981-09-03
ES505172A0 (es) 1983-07-01
FR2489145A1 (fr) 1982-03-05
CA1198679A (en) 1985-12-31
EP0047647A3 (en) 1982-09-15
JPS5780316A (en) 1982-05-19
IT1209894B (it) 1989-08-30
GB2082911A (en) 1982-03-17
NZ198259A (en) 1985-05-31
CH650148A5 (fr) 1985-07-15
ES8307491A1 (es) 1983-07-01
FR2489145B1 (cg-RX-API-DMAC10.html) 1984-05-25
EP0047647B1 (en) 1985-12-27
AU7486081A (en) 1982-03-11
FI812708L (fi) 1982-03-05

Similar Documents

Publication Publication Date Title
AU590403B2 (en) Pharmaceutical composition for the treatment of periodontal diseases
DE3173310D1 (en) Pharmaceutical compositions for promoting the healing of wounds
GB2118042B (en) Pharmaceutical compositions containing biphosphonic acids
DE3376957D1 (en) Pharmaceutical gel composition
GB2188844B (en) Pharmaceutical composition for the treatment of psoriasis
HUT48458A (en) Composition for promoting dosage of pharmaceutical compositions
IL68804A (en) 2-azetidinone-1-sulfonic acids,their manufacture and pharmaceutical compositions containing them
NZ218484A (en) Pharmaceutical compositions containing omental lipids for treatment of wounds
IL81001A0 (en) Compositions for bone healing containing omental lipids
IL76561A (en) Pharmaceutical compositions containing ifn-ypsilon for the treatment of rheumatic diseases
AU2199283A (en) Pharmaceutical compositions of m-chloro-alpha-t- butylaminopropiophenone
GB2091101B (en) Pharmaceutical composition comprising gammabutyro-betaine for the treatment of syndromes induced by l-carnitine deficiency
AU550675B2 (en) Pharmaceutical compositions for the treatment of skin
PT76657A (en) Process for preparing 4-aryl-4-piperidinecarbinols and of pharmaceutical compositions containing the same
PT77217A (en) Process for preparing 3-phenoxy-1-azetidine-carboxamides and of pharmaceutical compositions containing the same
BG49522A1 (en) Pharmaceutist composition accelarating the healing of mounds
ZA875847B (en) Pharmaceutical compositions for the treatment of occlusive vascular diseases
PT86776A (pt) Process for the preparation of piperazinecarboxylic acid and pharmaceutical compositions containing it
PT76951A (en) Process for the preparation of racemic or optically active eburnane-oxime derivatives and pharmaceutical compositions containing them
DE3272384D1 (en) Medicinal composition for the treatment of certain neuroviroses
EP0343671A3 (en) Pharmaceutical composition for the treatment of skin wounds
IL87182A0 (en) Pharmaceutical compositions containing tumor necrosis factor for treating infections
PT77282A (en) Process for preparing substituted 1-pyridyloxy-3-indolylalkylamino-2-propanols and of pharmaceutical compositions containing the same
IL63593A0 (en) Process for the preparation of new cytostatic compounds and pharmaceutical compositions containing them
PT76389B (en) Process for the preparation of 7-alpha-aminoacyl-3-chlorocepha-losporins having and anti-infections effect and their use for the preparation of pharmaceutical compositions having an anti-infections effect

Legal Events

Date Code Title Description
PCNP Patent ceased through non-payment of renewal fee